Log in
Enquire now
‌

US Patent 12016854 Liquid dosage forms to treat cancer

Patent 12016854 was granted and assigned to Exelixis, Inc on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Exelixis, Inc
Exelixis, Inc
0
Current Assignee
Exelixis, Inc
Exelixis, Inc
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120168540
Patent Inventor Names
Steven Lacy0
Gisela Schwab0
Khalid Shah0
Date of Patent
June 25, 2024
0
Patent Application Number
179757650
Date Filed
October 28, 2022
0
Patent Citations Received
‌
US Patent 12128039 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
0
Patent Primary Examiner
‌
Taylor V Oh
0
CPC Code
‌
A61P 35/00
0
‌
A61K 9/0053
0
‌
A61K 31/47
0
Patent abstract

This invention relates to a liquid pharmaceutical composition comprising cabozantinib to treat locally advanced or metastatic solid tumors, particularly advanced urothelial cancer or renal cell carcinoma in patients in need thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12016854 Liquid dosage forms to treat cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.